상단메뉴 바로가기 본문 바로가기 본문 하위메뉴 바로가기 하단 바로가기

Publications & Patents

HOMEPublications & Patents

Publications & Patents

게시글 검색
게시글 내용
No Title Writer Date Hit
Notice LyseNTech Patents List 운영자 2020-10-13 2262
14 2026. J Microbiol Biotechnol. Comparative Combinatorial Effects of Endolysins LNT103 with Ten Conventional Antibiotics against Gram-Negative Bacterial Pathogens Attachments LyseNTech 2026-07-21 32
13 2026. Int J Antimicrob Agents. Characterization and host range associating factors of Staphylococcus aureus bacteriophage PBSA08; Using Australian MRSA reference set Attachments LyseNTech 2026-07-21 32
12 2025 Int J Biol Macromol. In vitro and in vivo efficacy studies of an engineered endolysin targeting Gram-negative pathogens Attachments LyseNTech 2026-07-21 34
11 2024 IJAA_Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection Attachments Lysentech 2024-06-24 881
10 2024 J Biomed Sci._Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model Attachments Lysentech 2024-05-07 958
9 2024 Int J Biol Macromol._Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113 Attachments Lysentech 2024-01-23 1051
8 2023 Viruses_Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria Attachments Lysentech 2023-04-04 1340
7 2022 JMB_Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens Attachments Lysentech 2023-02-13 1508
6 2022 J Microbiol_Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin Attachments Lysentech 2023-02-10 1317
5 2022 Front. Microbiol_Motility increase of adherent invasive Escherichia coli (AIEC) induced by a sub-inhibitory concentration of recombinant endolysin LysPA90 Attachments Lysentech 2023-02-10 1330
12